GlassScriptPhysician profile
Kenneth M Belkoff
NPI 1760410526
$8,779.61
in general payments reported to CMS, 2019-2025
42 companies · $1,479 in 2025
The $1,479 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,171 · 2020: $391 · 2021: $825 · 2022: $775 · 2023: $2,693 · 2024: $1,444 · 2025: $1,479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,723 · Consulting Fee: $1,515 · Travel and Lodging: $379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,723.14 |
| Consulting Fee | $1,515.00 |
| Travel and Lodging | $378.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,802.05 | 2019-2025 | Erleada |
| Teleflex LLC | $1,070.23 | 2021-2025 | Urolift, Barrigel |
| Dendreon Pharmaceuticals LLC | $754.08 | 2019-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $440.83 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $430.67 | 2023-2025 | Orgovyx |
| Abbvie INC. | $406.67 | 2019-2025 | |
| Astellas Pharma US INC | $387.99 | 2019-2025 | Xtandi |
| Procept Biorobotics Corporation | $352.23 | 2022-2024 | Aquabeam System |
| Neotract INC. | $336.16 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $305.20 | 2021-2024 | Lynparza |
| Urogen Pharma, INC. | $251.63 | 2022-2025 | Jelmyto |
| Coloplast Corp | $248.44 | 2019-2025 | Speedicath |
| Ferring Pharmaceuticals INC. | $151.92 | 2019-2025 | Adstiladrin |
| Janssen Scientific Affairs, LLC | $149.99 | 2025 | |
| Myovant Sciences INC. | $144.82 | 2021-2022 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $139.34 | 2019-2023 | Yonsa, Odomzo |
| Agiliti Surgical, INC. | $131.00 | 2023 | Soltive |
| Amgen INC. | $125.58 | 2019-2023 | Prolia |
| Angiodynamics, INC. | $120.43 | 2025 | Nanoknife |
| Blue Earth Diagnostics | $107.02 | 2019-2022 | |
| Boston Scientific Corporation | $94.80 | 2019-2025 | Spaceoar Vue System - 10ml |
| Pfizer INC. | $91.35 | 2020-2025 | |
| Calyxo, INC. | $75.83 | 2023-2025 | Cvac Aspiration System |
| Immunitybio, INC. | $72.81 | 2024-2025 | |
| Tolmar Pharmaceuticals, INC. | $66.21 | 2019-2022 | |
| Novo Nordisk INC | $62.68 | 2025 | Rivfloza |
| Allergan, INC. | $61.67 | 2019-2021 | |
| Accord Healthcare, INC. | $47.68 | 2023-2024 | |
| Olympus America INC. | $47.23 | 2020-2023 | Itind System |
| Progenics Pharmaceuticals, INC. | $43.79 | 2024 | |
| Merck Sharp & Dohme LLC | $40.23 | 2022 | |
| Steris Corporation | $31.52 | 2025 | |
| Novartis Pharmaceuticals Corporation | $27.39 | 2024 | |
| Tolmar, INC. | $26.56 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $23.58 | 2023 | Seglentis |
| C. R. Bard, INC. & Subsidiaries | $23.07 | 2023 | Bard Urinary Drainage Bag |
| Endo USA, INC. | $19.37 | 2025 | Xiaflex, Aveed |
| Koelis INC. | $18.37 | 2023 | |
| Axonics, INC. | $15.44 | 2024 | Axonics |
| Therapeuticsmd, INC. | $11.57 | 2019 | |
| Zyla Life Sciences, INC. | $11.38 | 2019 | |
| Endo Pharmaceuticals INC. | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Belkoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.